Recent Security Class Actions

Vistagen Therapeutics Inc. Common Stock (NASDAQ: VTGN)

31 Days left to seek lead plaintiff status.

Company Name:Vistagen Therapeutics Inc. Common Stock
Stock Symbol:NASDAQ: VTGN
Class Period Start:04/01/2024
Class Period End (inclusive):12/16/2025
Filing Deadline:03/16/2026

According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning its Phase 3 PALISADE-3 trial study of fasedienol, an investigational pherine candidate in development for the acute treatment of social anxiety disorder.

Vistagen Therapeutics Inc. Common Stock (NASDAQ: VTGN) Claim Form

This field is for validation purposes and should be left unchanged.
Name(Required)
Address